Bacterial pneumonia is a frequent and deadly complication in hospitalized patients. Pseudomonas aeruginosa (PA) is an aerobic gram-negative bacterium that is the second most common cause of pneumonia in hospitalized patients, with mortality ranging from 60-90% in mechanically ventilated with pneumonia due to PA pneumonia. Innate host responses to PA are initiated by selected toll like receptors (TLR), including TLR4, which recognizes LPS, and TLR5, which is activated by flagellin. Flagellin stimulates protective immunity against diverse microbial pathogens, including bacteria and viruses. We have recently found that flagellin is a major inducer of the cationic peptide cathelicidin related antimicrobial peptide (CRAMP). CRAMP exerts important bactericidal and immunomodulatory properties that may contribute to the protective effects of flagellin observed in both infectious and non-infectious models. The central hypothesis of this revised proposal is that Pseudomonas flagellin stimulates protective lung innate mucosal immunity, which is mediated, in part, by the induction of the cationic antimicrobial peptide CRAMP.
The Specific Aims of the proposal are as follows:
Specific Aim 1. Determine the role of the cationic antimicrobial peptide CRAMP in mucosal innate responses during PA pneumonia Specific Aim 2. Determine the mechanism of flagellin-induced stimulation of protective lung innate antibacterial immunity The studies proposed will provide important insights into the role of cathelicidins in lung antibacterial host defense, and may potentially identify novel approaches to stimulate lung mucosal immunity that can be used to prevent or treat pneumonia in hospitalized patients.
Lung infection due to Pseudomonas aeruginosa continues to be a major cause of both morbidity and mortality in the United States. We have identified flagellin as a potent inducer of protective innate responses against this organism in experimental Pseudomonas pneumonia. Flagellin-induced protection is mediated, in part, by the antimicrobial peptide cathelicidin related antimicrobial peptide (CRAMP). The studies proposed in this application may identify novel means to prevent and possibly treat patients with respiratory tract infections due to P. aeruginosa.
|Liu, Xiaowei; Gao, Nan; Dong, Chen et al. (2014) Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection. Eur J Immunol 44:2667-79|
|Bhan, Urvashi; Newstead, Michael J; Zeng, Xianying et al. (2013) TLR9-dependent IL-23/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis. J Immunol 190:349-56|
|Yoon, Gi Sang; Dong, Chen; Gao, Nan et al. (2013) Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci 54:7510-21|
|Tolle, Leslie B; Standiford, Theodore J (2013) Danger-associated molecular patterns (DAMPs) in acute lung injury. J Pathol 229:145-56|
|Standiford, Louis R; Standiford, Theodore J; Newstead, Michael J et al. (2012) TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 302:L447-54|
|Kovach, Melissa A; Standiford, Theodore J (2012) The function of neutrophils in sepsis. Curr Opin Infect Dis 25:321-7|
|Moss, Marc; Standiford, Theodore J (2011) Leptin in fibroproliferative acute respiratory distress syndrome: not just a satiety factor. Am J Respir Crit Care Med 183:1443-4|
|Bhan, Urvashi; Newstead, Michael J; Zeng, Xianying et al. (2011) Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent. Am J Pathol 179:2779-87|
|Standiford, T J; Kuick, R; Bhan, U et al. (2011) TGF-?-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene 30:2475-84|
|Yu, Fu-shin; Cornicelli, Matthew D; Kovach, Melissa A et al. (2010) Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J Immunol 185:1142-9|
Showing the most recent 10 out of 11 publications